Senate, House Republicans Challenge Biden Admin to Reveal Funding Plan for $3 Billion Drug Rx Price-Fixing Effort

Senate, House Republicans Challenge Biden Admin to Reveal Funding Plan for $3 Billion Drug Rx Price-Fixing Effort
Rep. Jason Smith (R-Mo.) at a Make America Great Again rally in Springfield, Mo., Sept. 21, 2018. Charlotte Cuthbertson/The Epoch Times
Mark Tapscott
Updated:
0:00

Two GOP House committee chairmen and the top Senate Finance Committee Republican are challenging President Joe Biden to make public the spending plan for an obscure $3 billion prescription drug price-fixing fund established by the Inflation Reduction Act of 2022.

“Unfortunately, the so-called Inflation Reduction Act enacted last year has doubled down on the recent trend of federal expansion and excessive expenditures. The partisan law, for instance, directs a baffling $3 billion to the implementation of misguided price controls that pose serious risks for current and future patients, as well as for our international leadership in medical innovation,” the trio of congressional Republican leaders said in a Feb. 23 letter.
Mark Tapscott
Mark Tapscott
Senior Congressional Correspondent
Mark Tapscott is an award-winning senior Congressional correspondent for The Epoch Times. He covers Congress, national politics, and policy. Mr. Tapscott previously worked for Washington Times, Washington Examiner, Montgomery Journal, and Daily Caller News Foundation.
twitter
Related Topics